A lot of B2B pipelines look healthy
A lot of B2B pipelines look healthy. They aren’t.
They are just full of the wrong buyers.
And most teams only realize it months later, when “strong pipeline” quietly turns into missed quota.
It usually starts with the ICP slide.
“US based SaaS 200–2000 employees Uses Salesforce.”
It gets written once.
It looks tidy in the deck. Then it becomes a substitute for understanding the buyer.
Reps memorize the slide. But they do not know the person.
You can see the damage in every stage of the deal.
T͟o͟p͟ ͟o͟f͟ ͟f͟u͟n͟n͟e͟l͟ Calendars fill with meetings that were never a real fit.
D͟i͟s͟c͟o͟v͟e͟r͟y͟ Questions sound polished. But they could apply to almost anyone.
The buyer does not feel understood.
D͟e͟m͟o͟ The conversation drifts into a feature tour.
L͟a͟t͟e͟ ͟s͟t͟a͟g͟e͟ Pipeline still looks healthy. But it is full of “nice to have” deals.
They stall.
Then they end with: “Timing is not right.”
Post sale The product never quite fits their workflow or maturity.
Churn shows up early. Expansion never happens.
Most teams treat this like a sales execution problem. It usually is not.
It is an ICP problem. A real ICP is not a company description.
It is a specific buyer in a specific situation. You should be able to name:
Who gets value quickly, with low friction What they are replacing or trying to avoid
What pressure they are under board, CFO, security, operations
What constraints shape the decision data, process, internal politics
If you cannot answer these clearly, every stage becomes guesswork. Good sellers try to compensate with effort.
More meetings. More follow ups. More “staying close.”
But effort does not fix fit.
When your ICP is thin, you do not miss quota because you lack activity. You miss because your best activity is spent on the wrong situations.
Where is your team still using the slide version of ICP when the deal actually depends on the lived version?
♻️ Repost to help someone in your network 🔔 Follow Barry Flanagan for Daily AI + Tech Sales insights.